Maximum A Posteriori Bayesian Estimation of Oral Cyclosporin Pharmacokinetics in Patients with Stable Renal Transplants
- 1 January 2002
- journal article
- clinical trial
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 41 (1) , 71-80
- https://doi.org/10.2165/00003088-200241010-00006
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Application of a Gamma Model of Absorption to Oral CyclosporinClinical Pharmacokinetics, 2001
- Impact of Absorption Profiling on Efficacy and Safety of Cyclosporin Therapy in Transplant RecipientsClinical Pharmacokinetics, 2000
- Methods for Clinical Monitoring of Cyclosporin in Transplant PatientsClinical Pharmacokinetics, 2000
- NEORAL MONITORING BY SIMPLIFIED SPARSE SAMPLING AREA UNDER THE CONCENTRATION-TIME CURVETransplantation, 1999
- Abbreviated Pharmacokinetic Profiles in Area-Under-the-Curve Monitoring of Cyclosporine Therapy in De Novo Renal Transplant Patients Treated with Sandimmune or NeoralTherapeutic Drug Monitoring, 1999
- Challenges in Cyclosporine Therapy: The Role of Therapeutic Monitoring by Area Under the Curve MonitoringTherapeutic Drug Monitoring, 1995
- Evaluation of a Bayesian Approach to the Pharmacokinetic Interpretation of Cyclosporin Concentrations in Renal Allograft RecipientsTherapeutic Drug Monitoring, 1994
- Cyclosporine Monitoring in Renal TransplantationTherapeutic Drug Monitoring, 1989
- Optimal sampling times for pharmacokinetic experimentsJournal of Pharmacokinetics and Biopharmaceutics, 1981
- Some suggestions for measuring predictive performanceJournal of Pharmacokinetics and Biopharmaceutics, 1981